Patent · US Active

3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives

US8389526B2 · kind B2 · utility

4Cited by

4References

9Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Pascal Furet · Basel, CH
Clive McCarthy · Woodstock, GB
Joseph Schoepfer · Riehen, CH
Stefan Stutz · Basel, CH

Key dates

Filing date	Aug 3, 2010
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Sep 21, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I) and salts thereofwherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.